Impact of smoking on Gingival Crevicular Fluid and Salivary Periostin levels in Periodontitis Patients following Non-surgical periodontal therapy
Abdelazim, A., Hussine, A., Shaker, O., Ahmed, E. (2022). Impact of smoking on Gingival Crevicular Fluid and Salivary Periostin levels in Periodontitis Patients following Non-surgical periodontal therapy. EKB Journal Management System, 68(3), 2443-2456. doi: 10.21608/edj.2022.139609.2115
Amira Abdelazim; Amal Hussine; Olfat Shaker; Enji Ahmed. "Impact of smoking on Gingival Crevicular Fluid and Salivary Periostin levels in Periodontitis Patients following Non-surgical periodontal therapy". EKB Journal Management System, 68, 3, 2022, 2443-2456. doi: 10.21608/edj.2022.139609.2115
Abdelazim, A., Hussine, A., Shaker, O., Ahmed, E. (2022). 'Impact of smoking on Gingival Crevicular Fluid and Salivary Periostin levels in Periodontitis Patients following Non-surgical periodontal therapy', EKB Journal Management System, 68(3), pp. 2443-2456. doi: 10.21608/edj.2022.139609.2115
Abdelazim, A., Hussine, A., Shaker, O., Ahmed, E. Impact of smoking on Gingival Crevicular Fluid and Salivary Periostin levels in Periodontitis Patients following Non-surgical periodontal therapy. EKB Journal Management System, 2022; 68(3): 2443-2456. doi: 10.21608/edj.2022.139609.2115

Impact of smoking on Gingival Crevicular Fluid and Salivary Periostin levels in Periodontitis Patients following Non-surgical periodontal therapy

Egyptian Dental Journal
Article 21, Volume 68, Issue 3, July 2022, Page 2443-2456  XML PDF (502.09 K)
Document Type: Original Article
DOI: 10.21608/edj.2022.139609.2115
View on SCiNiTO View on SCiNiTO
Authors
Amira Abdelazim email orcid 1; Amal Hussineorcid 1; Olfat Shakerorcid 2; Enji Ahmedorcid 3
1Oral Medicine and Periodontology Department, Faculty of Dentistry, Cairo University, Giza, Egypt
2Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Giza, Egypt.
3Oral Medicine and Periodontology Department, Faculty of Dentistry, Cairo University, Giza, Egypt Oral Medicine and Periodontology Department Faculty of Dentistry, The British University in Egypt, Elshorouk, Egypt
Abstract
Abstract:
Background: Smoking has been identified as a major risk factor for periodontal diseases which results in its rapid progression. Periostin is a matricellular protein that is highly expressed in periodontal ligament and was found to be downregulated during periodontal disease. The aim of this study was to evaluate the effect of non-surgical periodontal therapy on clinical parameters as well as GCF and salivary periostin level in smoker and non-smoker patients with stage II & III periodontitis.

Methods:
Sixty subjects participated and divided into 20 periodontally healthy participants three study groups: group I included 20 periodontally healthy participants, group II included 20 smoker patients with stage II-III periodontitis and group II included 20 non-smoker patients with stage II-III periodontitis. Both groups II and III received phase I periodontal therapy (subgingival scaling and root planing) . Clinical parameters (PI, GI, PD, CAL) were recorded and GCF and salivary samples were collected from both periodontitis groups at baseline and again 3 months after phase I therapy. Samples were then analyzed using ELISA for periostin levels.

Results: Non-surgical periodontal therapy resulted in significant improvement in clinical parameters and increase in GCF periostin level while reduction in salivary periostin level in both smokers and nonsmokers with more significant improvement in the non-smokers group.

Conclusion: In smoker periodontitis patients, periostin could act as a potential biomarker not only for disease progression activity, but also could be targeted for faster tissue repair and more attachment gain.
Keywords
Periostin; smoking; GCF; Saliva; Periodontitis
Statistics
Article View: 161
PDF Download: 165